Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, or a stereoisomer thereof; and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
本文提供了髓系细胞白血病1蛋白(Mcl-1)
抑制剂,其制备方法,相关的药物组合物,以及使用方法。例如,本文提供了Formula I的化合物或其立体异构体;以及其药用可接受盐和含有该化合物的药物组合物。本文提供的化合物和组合物可以用于治疗疾病或病况,如癌症。